GLP-1 psychological side effects: a psychiatrist’s view
As a physician-psychiatrist, I have watched the rise of GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) with genuine admiration.…
Doctors are concerned over ivermectin’s renewed popularity : NPR
Ivermectin’s reputation keeps growing as a kind of cure-all, even for cancer — despite evidence it doesn’t work.…
Stock and Share Market News, Economy and Finance News, Sensex, Nifty, Global Market, NSE, BSE Live IPO News
Motilal Oswal Nifty Microcap 250 Index Fund – Direct Plan – Growth Today’s value of ₹1000 SIP 3…
A Weight Loss Pill Is Here—And Will Be Available Sooner Than You Think
Everything To Know About The Wegovy Pill Guido Mieth – Getty Images The new Wegovy pill was just…
A Rare Cancer-Fighting Plant Compound has Finally Been Decoded
Anti-cancer plant enzyme uncovered by Tuan-Anh Nguyen and Dr Thu-Thuy Dang – UBC Okanagan Canadian researchers have figured…
Medicinal mushrooms blur the line between health and skincare
While some brands around the world have relied on their benefits for years, the enthusiasm surrounding medicinal mushrooms…
Appleton Nurse Practitioner Sentenced in Federal Unlawful Prescribing Case
Dec 30, 2025 | 8:00 AM
Local News, Ryan Brahm A nurse practitioner in Appleton has…
Wegovy pill is not America’s silver bullet
The US Food and Drugs Association (FDA) has this week approved a Wegovy weight-loss pill, a more convenient…
Appetite drugs change grocery shopping habits in households
A new analysis of millions of shopping receipts reveals that popular GLP-1 weight-loss drugs such as Ozempic and…
Revisited: do medicinal mushroom products actually work? – podcast | Science
More of us are turning to products containing mushroom extracts, with the medicinal fungi market worth billions of…
Biography: Edge-based scientist explores the ether
Lilly Kolisko was born in Vienna, but settled in Edge near Stroud in the 1930s. The recently released biography…
Australians to pay no more than $25 for prescription drugs as Pharmaceutical Benefits Scheme co-payments slashed
The cost of medicines on Australia’s Pharmaceutical Benefits Scheme will be capped at $25 per script from Thursday,…